Federal Contractor Profile
Amgen USA INC
$968M obligated·16 awards·3 agencies·3 NAICS
Federal Contracts
Showing contracts 1–18 of 18 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Mar 6, 2026 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50122C00065 | 541714 | TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN. | $60M |
| Jul 15, 2025 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50122C00065 | 541714 | TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN. | $90M |
| Sep 18, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50122C00065 | 541714 | TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN. | $129M |
| Aug 8, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50124C00011 | 541714 | VENDOR MANAGED INVENTORY (VMI) SERVICES FOR USG PROCURED 165,906 DOSES OF NEULASTA PRODUCT TO MITIGATE INJURIES CAUSED BY EXPOSURE TO CHEMICAL, BIOLOGICAL THREAT AGENTS, PHYSICAL, RADIOLOGIC AND NUCLEAR EXPOSURES. | $274K |
| Mar 12, 2024 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50124C00011 | 541714 | VENDOR MANAGED INVENTORY (VMI) SERVICES FOR USG PROCURED 165,906 DOSES OF NEULASTA PRODUCT TO MITIGATE INJURIES CAUSED BY EXPOSURE TO CHEMICAL, BIOLOGICAL THREAT AGENTS, PHYSICAL, RADIOLOGIC AND NUCLEAR EXPOSURES. | $580K |
| Oct 1, 2023 | Department of Veterans Affairs260-NETWORK CONTRACT OFFICE 20 (36C260) | 36C26024F0036 | 325412 | TAVNEOS (AVACOPAN) | $129K |
| Sep 20, 2023 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50122C00065 | 541714 | TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN. | $205M |
| Sep 7, 2023 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118F33003 | 325414 | RTOR NUMBER: RTOR-CSF-0004 MAINTENANCE OF PREVIOUSLY PURCHASED COLONY STIMULATING FACTOR(S) (G- OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION | $66K |
| Sep 7, 2023 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118F33004 | 325414 | IGF::OT::IGF RTOR NUMBER: RTOR-CSF-0005 ACQUISITION OF COLONY STIMULATING FACTOR(S) (G-CSF OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION | $50K |
| Sep 28, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50122C00065 | 541714 | TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN. | $290M |
| Sep 13, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118F33003 | 325414 | RTOR NUMBER: RTOR-CSF-0004 MAINTENANCE OF PREVIOUSLY PURCHASED COLONY STIMULATING FACTOR(S) (G- OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION | $49K |
| Apr 1, 2021 | Department of Veterans Affairs245-NETWORK CONTRACT OFFICE 5 (36C245) | 36C24521F0279 | 325412 | AFLURIA QUADRIVALENT 0.5ML SINGLE-DOSE, PRE-FILLED QUADRIVALENT SYRINGES DESIGNATED FOR PERSONS 36 MONTHS AND OLDER PKG OF 10, NDC: 33332-0321-01 | $75K |
| Mar 31, 2021 | Department of JusticeFCI TERMINAL ISLAND | 15B61421FWB110130 | 325412 | TO PROVIDE FLU SHOTS FOR FY 2021 FOR STAFF AT THE FEDERAL CORRECTIONAL INSTITUTION TERMINAL ISLAND, CA. | $8K |
| Mar 31, 2021 | Department of JusticeFCI TERMINAL ISLAND | 15B61421FWB110130 | 325412 | TO PROVIDE FLU SHOTS FOR FY 2021 FOR STAFF AT THE FEDERAL CORRECTIONAL INSTITUTION TERMINAL ISLAND, CA. | $3K |
| Mar 31, 2021 | Department of JusticeFCI TERMINAL ISLAND | 15B61421FWM410004 | 325412 | TO PROVIDE FLU SHOTS FOR FY 2021 FOR STAFF AT THE FEDERAL CORRECTIONAL INSTITUTION TERMINAL ISLAND, CA. | $3K |
| Sep 13, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118F33004 | 325414 | IGF::OT::IGF RTOR NUMBER: RTOR-CSF-0005 ACQUISITION OF COLONY STIMULATING FACTOR(S) (G-CSF OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION | $154M |
| Aug 20, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50118F33003 | 325414 | RTOR NUMBER: RTOR-CSF-0004 MAINTENANCE OF PREVIOUSLY PURCHASED COLONY STIMULATING FACTOR(S) (G- OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION | $542K |
| Sep 30, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO10033002T | 325414 | IGF::OT::IGF FOR OTHER FUNCTIONS PROJECT: ACQUISITION OF COLONY STIMULATING FACTOR(S) (G-CSF OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION (RTOR-CSF-0003) | $38M |
Get Alerted Before Amgen USA INC's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free